2024-03-01 2024-03-01 , online online, 1,330 € plus tax Dr. Christopher Brückner https://www.forum-institut.com/seminar/24051130-spc-update/referenten/24/24_05/24051130-course-supplementary-protection-certificates,-spcand-management_brueckner-christopher.jpg SPC Update

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course
  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Santen: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals: what to expect from Maylan (C-473/22) and Teva v MSD (C-119/22)


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this FORUM!Live online course is intended for you. Prior knowledge of patents is a requisite.
The objectives of your online course
In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers. Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As 2024 might see a wide-reaching reform of the SPC law with, among others, a unitary SPC, our speaker will give you an overview and will explain to you what changes can be expected.
Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Course - Supplementary Protection Certificates, SPC and the ECJ

SPC Update

EU Reform And Case-Law

Benefits
  • Latest developments in brief
  • Optional booking: pre-course
  • Participants will receive a copy of the 3rd edition of the SPC commentary - registration
made by 29 February

Webcode 24051130

Book now

JETZT Buchen

Speaker


Everything at a glance

Appointment

15-16/05/2024

15-16/05/2024

Period

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET
Venue

online

online

Fee
Your contact

Jean-Claude Alexandre Ho, LL.M.
Lawyer, Conference Manager

+49 6221 500-675
jc.alexandreho@forum-institut.de

Details

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course

  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Santen: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals: what to expect from Maylan (C-473/22) and Teva v MSD (C-119/22)


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this FORUM!Live online course is intended for you. Prior knowledge of patents is a requisite.

The objectives of your online course

In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers. Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As 2024 might see a wide-reaching reform of the SPC law with, among others, a unitary SPC, our speaker will give you an overview and will explain to you what changes can be expected.

Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Detailed programme

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Introduction to the basic terms
  • Structure of the EU SPC Regulation for Medicinal Products
  • Product - relevant deadlines - basic patent - relevant marketing authorization

Fundamental practical questions
  • What can be protected?
  • Application for a certificate based on third parties' authorisation
  • Date of grant of the basic patent and the marketing authorization

SPC key issues

SPC reform
  • Unitary SPC
  • Further changes

Medeva, Eli Lilly, Actavis and Georgetown II referrals: laying the ground

From Merck vs Sigma to Santen
  • Merck v Sigma (C-579/13), Pfizer Ireland (C-681/16): referrals on Specific Mechanism
  • Synflorix (C-631/13): definition of adjuvant
  • Boehringer (C-577/13): combination claimed in second patent
  • Forsgren (C-631/13): covalent binding of a biologic product
  • Seattle Genetics (C-471/14): date of market authorisation
  • F. Hoffmann - La Roche (C-572/15): duration of an SPC issued under national law
  • Incyte (C-492/16): date of expiry of an SPC
  • MSD (C-567/16): end of procedure notice equivalent to market authorisation?
  • Teva v Gilead (C-121/17): product protected by a basic patent in force
  • Boston Scientific (C-527/17): no SPCs for CE-marked devices
  • Abraxis (C-443/17): first marketing authorisation for new formulations
  • QH/Royalty Pharma (C 650/17): individualized embodiment
  • Santen v INPI (C-673/18): no SPC for new therapeutic applications

Pending referrals: what to expect
  • Mylan (C-473/22): liability for enforcing a later invalid patent
  • Teva v MSD (C-119/22): "product" in Art 3(a) and Art 3(c)

More informations

Agenda

The agenda hast been adapted speifically to the medium and the respective seminar.

It is as follows:

Pre-course: Introduction to SPC
15 May 2024 I Online
starts at 13:00 CET, ends at 17:15 CET
breaks at 14:15 and 15:45 CET

Advanced course: SPC Update
16 May 2024 I Online
starts at 09:00 CET, ends at 17:00 CET
breaks at 10:30, 12:15 and 15:30 CET

BONUS

Each participant will receive a copy of the 3rd edition of the SPC commentary by Dr. Brückner, the standard reference, if registration is made by 29 February 2024.

Introduction to SPC

Attendees without prior SPC knowledge/ education are advised to attend the introduction to SPC pre-course on 15 May 2024.

This distinguishes our events

Very informative and thought-provoking.

Very informative and thought-provoking.

Recommendations

IP Agreements - Patent License Agreements

Participants, doing business in a complex multi-jurisdictional environment, will be enabled to address difficult situati...

13.03.2024, Online
Details

OECD BEPS from an IP management perspective

This special course for IP professionals aims at providing them knowledge on OECD BEPS and teach them how to deal with t...

30.05.2024, Online
Details

IP Key Metrics

This FORUM!Live online course is about key metrics for IP. Attendees will learn how to measure IP KPIs.

16.04.2024, Online
Details

Webcast: UPC Fireside Chat

This live webcast provides you regularly with the discussion of the latest UPC cases and their impact on legal practice.

07.03.2024, Online
Details

IP Protection for Plant Innovation 2024

The conference offers you once again the most recent developments in IP for the seed industry and the breeders.

13. - 14.06.2024 in Amsterdam
Details

Go forward

White paper: Inside the Patent Factory

Download this whitepaper and get insights on the patent creation process.

Details
White paper: Inside the Patent Factory
White paper: Research and Development Agreements

Download the checklist with typical R&D agreements clauses.

Details
White paper: Research and Development Agreements
White paper: IP strategy - where to start

Download this whitepaper with the views of ~400 IP professionals.

Details
White paper: IP strategy

Testimonials

Testimonial
'This is really helpful for building our IP department. What I liked most: the practical applicability of the course content. Excellent course for portfolio managers.'

Jan-Willem Louwaard, IP Senior Manager

Tenaris Connections


'The course has met my expectations. I liked that the course was practical.'

Jean-Christophe Raboin, European Patent Attorney

Total


'Good insight in portfolio management, practical tools, templates.'

European Patent Attorney